The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Toddler born deaf can hear after world-first gene therapy
Gene therapy trial for child deafness. Is this going to affect GDR?
https://www.thetimes.co.uk/article/8d5b73af-0638-4801-857a-6c1067162b09?shareToken=9ae8e490f69d9b6e77a48ead3fd6dcdc
Wouldn’t think so Nigh as prevention is better than cure.
S*it....down another 10% today...!!
It’s like saying why test for cancer when it can occasionally be cured
It Shouldn’t change anything here
I wish we had their PR department , this is making headline news
Guy - bid down to 2.75p. What’s your gut feeling on GDr being taken private and delisting?
Rog ..sorry to but in ...at the presentation when asked about going "Private "...JC was caught out with that question, highly likey this is going Private and de-listing....imho..for what its worth
If it does go private, where would that leave the shareholders ?
And if you truly think that System why are you still here? If I was convinced of that I’d sell up immediately. I’m not convinced that’s what will happen…yet and so remain highly interested in what happens here over the next few weeks.
If Cheek manages to save GDR then imagine the rewards by buying in now when the sp is almost below 3p. High risk yes but potentially a 4-bagger even if the sp gets to just 12p
I’m still thinking most likely outcome now is a lowball offer to buy GDR. I’m hoping that will be at about 5,6 or 7p per share so I can double my investment - sorry, punt - from here. If there was a bid of £10m so much the better and I’d now take that. If the sp drops further I’m gambling on about £25k at 2.5p and then a takeover. GDR can’t survive on its own but the IP is valuable and they’re almost over the line with a Full Recommendation from NICE. Unfortunately the 3month delay in getting that NICE news has done for GDR. I’m cynical and think it’s no coincidence this is how it’s all panned out. GDR so nearly nearly made it but there’s huge potential for making money out of their tests and so other players have got involved and manipulated the situation GDR now finds itself in. £10m to buy GDR would be an absolute bargain. Total annual costs £5m with a potential global revenue ten times that - and that’s achievable in just two to three years time.
Roger i don't think it'll go private , but then again a lot of what's happened I didn't think would happen 😵💫
The fact they haven't sorted funding yet gives me outside hope that something big might come first .. although there's always the fear that no one is willing to hand over any ££? I'd assume they would of had a drawdown if that was the case
Ultimately I can't/refuse to cash out at this point, the money in my eyes is lost so just hoping we get a miracle but the new owner is just more of the same as dudd
Who do you think would take GDR private? The current BOD? They don't own any shares do they?
Coughing up £5m or so and then raising the necessary funding privately is no mean task unless any of the board members are multimillionaires, which they aren't as far as i'm aware?
The most likely situation is that funding talks have broken down and are now desperately on going at the eleventh hour.
I don’t know who the major share holders in GDR are but cd something similar to what happened at e-therapeutics happen here too? We’re talking much smaller sums of money.
Interesting to read this from the e-therapeutics BODs ‘ s, the Board was extremely disappointed by the lack of institutional UK interest in our innovative, technology-driven value propositions.’. Funny that!
Segment on R4 this morning interviewing the CEO of the AIM listed Company explaining how over the last few years £1.9 trillion (I think it was trillion) of funding has now withdrawn from supporting smaller companies on the LSE. There are nothing like enough rewards for retail investors who risk losing every Penny they invest only to be thanked by the uk govt by paying 40% CGT! It’s no wonder the AIM market will be dismantled altogether in the next 5 years. And I don’t see a new Labour Govt coming to the rescue either.
HarChris - You need to do a bit more research. Dr Ian Gilham, Chairman of the BOD at GDR is a multimillionaire!!! He is also very well connected in the City of London with investors and fund managers. He is also extremely experienced in mergers and acquisitions and disposals of companies. He would have no problem taking GDR private. Do a little research on Dr Ian Gilham. Good luck. Atb Popeye
Will do Popeye, thanks.
As for E-therapeutics all I know is that that a single investor owned 30% and an institution another so just those two parties together controlled 60% of the company. Usually when public companies are taken private by the board the BOD already owns a large percentage of the shares to begin with.
Gilham could easily fund private. He’s sold companies in the pay for £100s of millions. Maybe this is why Cheek is happy to take things to the wire with regard to sorting the funding crisis?
Sorry Popeye, you beat me to it
Agh typos
*Gilham could easily fund going private. He’s sold companies in the past for £100s of millions
I am currently invested in REDX and ETX which have both gone private .I held the the shares which were in an ISA unfortunately cannot be retained in the ISA but moved to a non ISA account .Your broker if you want to trade share after delisting then your broker can set up a matched bargain facility with J P Jenkins which specialises in companies that have gone private . I read that there may many AIM companies consideration leaving the UK to seek more value with Nasdaq Great news for inherited hearing loss children perhaps GDR pharmacogenomics can develop a test for this rogue gene
Gilliham is on to high a pedestal, if he is so great he would have realised how useless Dudd was and got rid.
Then he should have put the squeeze on the 3 amigos!
Guy - what do you mean by ' but the new owner is just more of the same as dudd'?
A lot of big talk but absolutely nothing comes from it
Now we just await the inevitable rns of a raise where they blame market conditions but expect significant commercial opportunities in the next 12 months .. we’ve seen it all before
Just Bought another 1 k to average out ..
I dont see this company going not getting finance or being de listed .. far from .. the fact they have not issued a RNS about funding a simple placing tells me they have other plans , and a partner is coming in from the USA, think about it... the stroke device near NICE approval is a game changer ... worst case , this will do a pump to 20 p on that alone
Something not quit right here , why has my buy showing as a sell anyone ?
Big question for me is can they get to 10th July without doing a raise or taking another drawdown from RF. If that was manageable somehow then I think we'd see the sp rising. Even it turns out to be a sell-the-news event I think that would provide an opportunity for Cheek to do a placing at a fairer share price and give the open offer to existing and lths.
If it's full recommendation then within the 3 months the NHS will have to spell out how much funding will be used for the CYP2C19 test and in how many hospitals. If they are working off the 35k tests per year as stated in the NICE consultation documents then that's a heck of a change in GDR's selling fortunes. That would provide about £2.5m in revenue p.a. Together with increasing sales of RNR1 and the annual R& D refund GDR are tantalisingly close to becoming financially self sufficient. If Cheek can get a placing and open offer away at 5p for £2 to £3m then the short term outlook will be very very different. That's a positive spin on things.
More likely imv is that GDR can't survive until 10th July without either having to do a massive dilution and giving half the company away and issuing another 500m shares, taking more funds from RF - there is still £1.5m available to drawdown - or lastly being bought out at a cheap price. I have no clue what will happen but the days of dreaming the share price could once again reach the lofty heights of 20 - 30p are now well and truly over.
Roger , you need to ensure your mental health is taken care off ... Nothing in this life is over until its over .. big news on the way .. write it down some where .. so relax ..